chr12-49026431-G-C

Variant summary

Our verdict is Likely pathogenic.
+6 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 6 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_SupportingO3_ModerateO5_SupportingO6_SupportingO7_Supporting

The NM_003482.4(KMT2D):c.15535C>G (p.Arg5179Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The gene KMT2D is a tumor suppressor gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a known oncogene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a cancer driver gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.00). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R5179P: Likely_pathogenic (ClinVar VariationId 1513321, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R5179= (synonymous): Benign (ClinVar VariationId 2908675, 1 star) The variant position is a cancer hotspot (cancerhotspots.org) with 40 samples affected at this amino acid position.

Frequency

Genomes: not found (cov: 32)

Consequence

KMT2D
NM_003482.4 missense

Scores

11
6
1

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 8.00

Publications

3 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Illumina, PanelApp Australia
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, ClinGen
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003482.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 6 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP (single/no review) — Supporting (O1); O1 contributing sources (1.0 pts): ClinVar germline P/LP in TSG (★)
O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; Note: exclude MSK/TCGA-derived samples from cancerhotspots count to avoid double-counting with O4; cancerhotspots.org: total samples at AA position = 40, same AA change = 0; Exclude MSK/TCGA-derived samples from count to avoid double-counting with O4; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 1 pathogenic, 3 benign (OR vs. background: 2.1); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

KMT2D NM_003482.4
MANE Select
HGVSc / HGVSpc.15535C>Gp.Arg5179Gly
Exon rankExon 49 of 55
missense
Prot: NP_003473.3UniProt: O14686-1

Ensembl Transcripts

KMT2D ENST00000301067.12
TSL:5MANE Select
HGVSc / HGVSpc.15535C>Gp.Arg5179Gly
Exon rankExon 49 of 55
missense
Prot: ENSP00000301067.7UniProt: O14686-1
KMT2D ENST00000683543.2
HGVSc / HGVSpc.15535C>Gp.Arg5179Gly
Exon rankExon 49 of 56
missense
Prot: ENSP00000506726.1UniProt: A0A804HHR9
KMT2D ENST00000685166.1
HGVSc / HGVSpc.15544C>Gp.Arg5182Gly
Exon rankExon 48 of 54
missense
Prot: ENSP00000509386.1UniProt: O14686-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:33
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Kabuki syndrome 1 (1)

Computational Scores

AlphaGenome AVI
Pathogenic30
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.36D
BayesDel_noAF
Pathogenic0.28
CADD
Uncertain25
DANN
Uncertain0.98
DEOGEN2
Benign0.28T
Eigen
Pathogenic0.90
Eigen_PC
Pathogenic0.84
FATHMM_MKL
Uncertain0.97D
FuncVEP CTI
Pathogenic0.88
GPN-Star LLR
N/A-12
GPN-Star score
N/A12
LIST_S2
Uncertain0.97D
M_CAP
Pathogenic0.57D
MetaRNN
Pathogenic0.91D
MetaSVM
Uncertain0.59D
Mutation Taster
N/A11/89disease causing
MutationAssessor
Uncertain2.4M
PhyloP100
Pathogenic8.0
PrimateAI
Uncertain0.78T
PromoterAI
N/A0.015Neutral
PROVEAN
Pathogenic-6.7D
RBP_binding_hub_radar
N/A0.92
RBP_regulation_power_radar
N/A2.7
REVEL
Pathogenic0.82
Sift
Pathogenic0.0D
Varity_R
N/A0.92
VESM-3B
Benign-11
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.